Home/Filings/4/0001960596-25-000008
4//SEC Filing

Lawver Teri L 4

Accession 0001960596-25-000008

CIK 0000744218other

Filed

Nov 11, 7:00 PM ET

Accepted

Nov 12, 4:12 PM ET

Size

5.9 KB

Accession

0001960596-25-000008

Insider Transaction Report

Form 4
Period: 2025-11-10
Lawver Teri L
SVP & Chief Commercial Officer
Transactions
  • Award

    ISO (right to buy)

    2025-11-10+100,000100,000 total
    Exercise: $22.67From: 2026-11-10Exp: 2035-11-10Common Stock (100,000 underlying)
Footnotes (2)
  • [F1]Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
  • [F2]25% vest on November 10, 2026 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.

Issuer

Celldex Therapeutics, Inc.

CIK 0000744218

Entity typeother

Related Parties

1
  • filerCIK 0001960596

Filing Metadata

Form type
4
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 4:12 PM ET
Size
5.9 KB